Scarica l'app Stockscreener
1.32
1.49%
-0.02
Pre-mercato:
1.37
0.05
+3.79%
Precedente Chiudi:
$1.34
Aprire:
$1.35
Volume 24 ore:
20,024
Relative Volume:
0.20
Capitalizzazione di mercato:
$69.97M
Reddito:
$9.16M
Utile/perdita netta:
$-68.17M
Rapporto P/E:
-0.8098
EPS:
-1.63
Flusso di cassa netto:
$-80.16M
1 W Prestazione:
-3.65%
1M Prestazione:
+10.92%
6M Prestazione:
-19.51%
1 anno Prestazione:
-20.00%
Intervallo 1D:
$1.32
$1.35
Intervallo di 1 settimana:
$1.31
$1.365
Portata 52W:
$0.9707
$1.94
Ikena Oncology Inc Stock (IKNA) Company Profile
Nome
Ikena Oncology Inc
Settore
Industria
Telefono
857-343-8292
Indirizzo
50 NORTHERN AVE., BOSTON
Confronta IKNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IKNA
Ikena Oncology Inc
|
1.32 | 69.97M | 9.16M | -68.17M | -80.16M | -1.63 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-29 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-09-22 | Iniziato | Wedbush | Outperform |
| 2023-05-04 | Ripresa | H.C. Wainwright | Buy |
| 2021-12-23 | Iniziato | H.C. Wainwright | Buy |
| 2021-05-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-20 | Iniziato | Credit Suisse | Outperform |
| 2021-04-20 | Iniziato | Jefferies | Buy |
| 2021-04-20 | Iniziato | William Blair | Outperform |
Mostra tutto
Ikena Oncology Inc Borsa (IKNA) Ultime notizie
Two Sigma Investments LP Sells 55,935 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Squarepoint Ops LLC Acquires Shares of 43,640 Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Millennium Management LLC Trims Stake in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Citadel Advisors LLC Lowers Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Two Sigma Advisers LP Has $258,000 Stock Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology, Inc. (NASDAQ:IKNA) Shares Bought by Northern Trust Corp - Defense World
BNP Paribas Financial Markets Acquires New Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology Reports Q1 Loss Amid Merger Plans - TipRanks
Ikena Oncology Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Ikena Oncology, Inc. SEC 10-Q Report - TradingView
Renaissance Technologies LLC Sells 70,400 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Geode Capital Management LLC Purchases 56,936 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Marquis Who's Who Honors Wilmin P. Bartolini for Expertise in Pharmaceutical Consulting - 24-7 Press Release Newswire
Prudential Financial Inc. Trims Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology stock hits 52-week low at $0.98 amid market challenges - Investing.com Canada
Ikena Oncology stock hits 52-week low at $0.98 amid market challenges By Investing.com - Investing.com South Africa
Ikena Oncology stock hits 52-week low at $1.21 amid market challenges - Investing.com
Ikena Oncology stock hits 52-week low at $1.21 amid market challenges By Investing.com - Investing.com South Africa
Ikena Oncology Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares - Business Wire
Ikena Oncology: Investor Caution as Dividend Payments Remain Unlikely - TipRanks
Ikena Oncology Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Ikena Oncology Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Ikena Oncology, Inc. SEC 10-K Report - TradingView
Short Interest in Ikena Oncology, Inc. (NASDAQ:IKNA) Decreases By 11.8% - MarketBeat
Discovering February 2025's Promising Penny Stocks On US Exchanges - Simply Wall St
Ikena Oncology (NASDAQ:IKNA) Stock Price Down 0.7%Here's Why - MarketBeat
A History of Outperforming Analyst Forecasts and Beating the Odds: Ikena Oncology Inc (IKNA) - SETE News
Understanding the Risks of Investing in Ikena Oncology Inc (IKNA) - Knox Daily
Ikena Oncology Merger with Inmagene Biopharmaceuticals and Private Placement Financing - Leerink Partners
Jane Street Group LLC Sells 18,570 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Geode Capital Management LLC Acquires 14,319 Shares of Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
How former leaders of a sold-off biotech company landed their drugs again - The Business Journals
Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular - Scrip
US Penny Stocks To Watch In January 2025 - Simply Wall St
Ikena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade - MSN
Ikena Oncology and Inmagene Biopharmaceuticals to Merger - citybiz
Inmagene takes back-door route to Nasdaq listing - The Pharma Letter
Ikena Oncology, Inc. announced that it expects to receive $75 million in funding from a group of investors - Marketscreener.com
Five things you need to know, and a Chrismukkah throwback - The Business Journals
Ikena Oncology, Inc. (NASDAQ:IKNA) Shares Purchased by Fmr LLC - Defense World
Ikena Oncology Enters into Merger Agreement with Inmagene BiopharmaceuticalsOn December 23, 2024, Ikena Oncology, Inc. (NASDAQ: IKNA) announced a significant development as it entered into a Merger Agreement with Inmagene Biopharmaceuticals. - Defense World
Boston biotech opts for reverse merger with San Diego company - The Business Journals
Ikena Oncology Shares Rise After Merger Announcement With Inmagene Biopharmaceuticals - MarketWatch
Ikena Oncology and Inmagene Biopharmaceuticals announces merger - MSN
Ikena, after tough year of layoffs, merges with Inmagene to focus on phase 2 dermatitis prospect - Fierce Biotech
3 US Penny Stocks With Market Caps Over $40M To Consider - Yahoo Finance
Ikena Oncology Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.40 loss in 3Q 2023) - Yahoo Finance
Ikena Oncology Reports Third Quarter 2024 Financial Results - GlobeNewswire
On Ikena Oncology ($IKNA) Setting up a Sale - substack.com
Ikena Oncology Inc Azioni (IKNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):